Quantum X Labs Inc. QXL
5.00
(0.17)
(3.29%)
as of 25 Sep
- Market cap
- $111.8M
- P/E
- 34.2×
Follow QXL
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(253.47%) | (308.66%) | (106.34%) | (13.37%) | |
| (92.30%) | (117.87%) | (59.95%) | (8.11%) | ||
ROIC |
16.09% | (21.18%) | (7.56%) | 1.93% | |
Return on Tangible Assets |
503.80% | 818.90% | 1,243.07% | 602.61% | |
Average Days of Receivables |
(32.22) | 73.28 | 177.91 | 171.96 | |
Free Cash Flow per Share |
(0.30) | (0.33) | (0.31) | (0.30) | |
Free Cash Flow |
(3.14) | (2.77) | (3.56) | (4.34) | |
Capital Expenditures |
— | — | — | (0.19) | |
Piotroski F-Score |
2.00 | 2.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(26.35%) | (32.50%) | (13.80%) | (13.74%) | |
Accounts Receivable Turnover |
(4.05) | 3.60 | 1.62 | 1.58 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.02) | 0.00 | (0.01) | (0.96) | |
Research and Development Expense of Revenue |
4.12% | 4.40% | 0.00% | 18.09% | |
Selling, General and Administrative Expense of Revenue |
(3.87%) | 109.94% | 145.94% | 188.91% | |
Share Based Compensation of Revenue |
(0.40%) | 4.97% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.14 | 0.14 | 0.22 | 1.99 | |
Depreciation/Fixed assets |
19.85 | 15.14 | 20.43 | 4.35 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.22) | |
Revenue per Share |
(1.43) | 0.19 | 0.12 | 0.09 | |
Operating CF per Share |
(0.30) | (0.33) | (0.31) | (0.29) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.15 | |
Net Profit Margin |
146.40% | (1,229.13%) | (1,164.54%) | (157.98%) |
Columns are period end dates